181 related articles for article (PubMed ID: 27503781)
1. Observation of clinical efficacy of photodynamic therapy in 3 patients with refractory plaque-stage mycosis fungoides.
Han D; Xue J; Wang T; Liu Y
Photodiagnosis Photodyn Ther; 2016 Dec; 16():9-11. PubMed ID: 27503781
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy as an alternative treatment for mycosis fungoides: a systemic review and meta-analysis.
Seyed Jafari SM; Cazzaniga S; Hunger RE
G Ital Dermatol Venereol; 2018 Dec; 153(6):827-832. PubMed ID: 29683282
[TBL] [Abstract][Full Text] [Related]
3. Remission of a cutaneous Mycosis fungoides after topical 5-ALA sensitisation and photodynamic therapy in a patient with advanced HIV-infection.
Paech V; Lorenzen T; Stoehr A; Lange K; Merz H; Meigel WN; Plettenberg A
Eur J Med Res; 2002 Nov; 7(11):477-9. PubMed ID: 12568975
[TBL] [Abstract][Full Text] [Related]
4. Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literature.
Recio ED; Zambrano B; Alonso ML; de Eusebio E; Martín M; Cuevas J; Jaén P
Int J Dermatol; 2008 Apr; 47(4):410-3. PubMed ID: 18377612
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy with methyl-aminolaevulinic acid for mycosis fungoides.
Kim ST; Kang DY; Kang JS; Baek JW; Jeon YS; Suh KS
Acta Derm Venereol; 2012 May; 92(3):264-8. PubMed ID: 22170261
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: a prospective open study and review of the literature.
Quéreux G; Brocard A; Saint-Jean M; Peuvrel L; Knol AC; Allix R; Khammari A; Renaut JJ; Dréno B
J Am Acad Dermatol; 2013 Dec; 69(6):890-7. PubMed ID: 24041738
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response.
Edström DW; Porwit A; Ros AM
Acta Derm Venereol; 2001; 81(3):184-8. PubMed ID: 11558874
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application.
Orenstein A; Haik J; Tamir J; Winkler E; Trau H; Malik Z; Kostenich G
Dermatol Surg; 2000 Aug; 26(8):765-9; discussion 769-70. PubMed ID: 10940064
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid.
Wolf P; Fink-Puches R; Cerroni L; Kerl H
J Am Acad Dermatol; 1994 Oct; 31(4):678-80. PubMed ID: 8089302
[No Abstract] [Full Text] [Related]
10. Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma.
Zane C; Venturini M; Sala R; Calzavara-Pinton P
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):254-8. PubMed ID: 16948827
[TBL] [Abstract][Full Text] [Related]
11. [Plaque-phase mycosis fungoides treated with photodynamic therapy: results from 12 patients].
Fernández-Guarino M; Harto A; Pérez-García B; Montull C; De Las Heras E; Jaén P
Actas Dermosifiliogr; 2010 Nov; 101(9):785-91. PubMed ID: 21034709
[TBL] [Abstract][Full Text] [Related]
12. Mycosis fungoides showing incomplete response to topical 5-aminolaevulinic acid phototherapy.
Kim EH; Kang HY; Lee ES; Kim YC
Eur J Dermatol; 2007; 17(4):343-5. PubMed ID: 17540651
[No Abstract] [Full Text] [Related]
13. Topical 5-aminolaevulinic acid photodynamic therapy for tumour-stage mycosis fungoides.
Markham T; Sheahan K; Collins P
Br J Dermatol; 2001 Jun; 144(6):1262-3. PubMed ID: 11422054
[No Abstract] [Full Text] [Related]
14. A case of photocontact urticaria induced by photodynamic therapy with topical 5-aminolaevulinic acid.
Yokoyama S; Nakano H; Nishizawa A; Kaneko T; Harada K; Hanada K
J Dermatol; 2005 Oct; 32(10):843-7. PubMed ID: 16361740
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy and plaque phase mycosis fungoides.
Fernández-Guarino M; Jaén P
G Ital Dermatol Venereol; 2011 Dec; 146(6):457-61. PubMed ID: 22095177
[TBL] [Abstract][Full Text] [Related]
16. Topical photodynamic therapy with 5-aminolevulinate for the treatment of tumor-stage mycosis fungoides: a case report.
Hasson A; Navarrete-Dechent C; Nicklas C; Sazunic I
Int J Dermatol; 2013 Dec; 52(12):1535-7. PubMed ID: 24134456
[No Abstract] [Full Text] [Related]
17. Photodynamic therapy as an alternative treatment for relapsed or refractory mycosis fungoides: A systemic review.
Xue J; Liu C; Liu Y
Photodiagnosis Photodyn Ther; 2017 Mar; 17():87-91. PubMed ID: 27888162
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy with methyl aminolaevulinate for cervical and/or facial lesions of folliculotropic mycosis fungoides: interest and limits.
Debu A; Bessis D; Girard C; Du Thanh A; Guillot B; Dereure O
Br J Dermatol; 2013 Apr; 168(4):896-8. PubMed ID: 23013351
[No Abstract] [Full Text] [Related]
19. Photodynamic therapy: An option in mycosis fungoides.
Pileri A; Sgubbi P; Agostinelli C; Infusino SD; Vaccari S; Patrizi A
Photodiagnosis Photodyn Ther; 2017 Dec; 20():107-110. PubMed ID: 28890210
[TBL] [Abstract][Full Text] [Related]
20. The effect of psoralen plus ultraviolet A in vitro in HUT-78 enhances by 5-aminolevulinic acid.
Akita Y; Watanabe D; Yanagishita T; Kuhara T; Kawamura C; Masuda Y; Kawada M; Nakaseko H; Tamada Y; Matsumoto Y
Photodermatol Photoimmunol Photomed; 2007; 23(2-3):95-7. PubMed ID: 17523931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
